A retrospective, multicenter review assessing clinical features and treatment outcomes of patients with peripapillary choroidal neovascular membrane (CNVM) secondary to idiopathic intracranial hypertension (IIH)
Latest Information Update: 11 Aug 2020
At a glance
- Drugs Aflibercept (Primary) ; Bevacizumab (Primary) ; Ranibizumab (Primary)
- Indications Choroidal neovascularisation
- Focus Therapeutic Use
Most Recent Events
- 11 Aug 2020 New trial record